<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="jco"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4962704/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962704/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Journal of Clinical Oncology"><meta name="citation_title" content="Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia"><meta name="citation_authors" content="Chengcheng Liu, Wenjian Yang, Meenakshi Devidas, Cheng Cheng, Deqing Pei, Colton Smith, William L. Carroll, Elizabeth A. Raetz, W. Paul Bowman, Eric C. Larsen, Kelly W. Maloney, Paul L. Martin, Leonard A. Mattano, Jr, Naomi J. Winick, Elaine R. Mardis, Robert S. Fulton, Deepa Bhojwani, Scott C. Howard, Sima Jeha, Ching-Hon Pui, Stephen P. Hunger, William E. Evans, Mignon L. Loh, Mary V. Relling"><meta name="citation_date" content="20 June 2016"><meta name="citation_issue" content="18"><meta name="citation_volume" content="34"><meta name="citation_firstpage" content="2133"><meta name="citation_doi" content="10.1200/JCO.2015.64.5812"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4962704/?report=abstract"><meta name="citation_pmid" content="27114598"><meta name="DC.Title" content="Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Society of Clinical Oncology"><meta name="DC.Contributor" content="Chengcheng Liu"><meta name="DC.Contributor" content="Wenjian Yang"><meta name="DC.Contributor" content="Meenakshi Devidas"><meta name="DC.Contributor" content="Cheng Cheng"><meta name="DC.Contributor" content="Deqing Pei"><meta name="DC.Contributor" content="Colton Smith"><meta name="DC.Contributor" content="William L. Carroll"><meta name="DC.Contributor" content="Elizabeth A. Raetz"><meta name="DC.Contributor" content="W. Paul Bowman"><meta name="DC.Contributor" content="Eric C. Larsen"><meta name="DC.Contributor" content="Kelly W. Maloney"><meta name="DC.Contributor" content="Paul L. Martin"><meta name="DC.Contributor" content="Leonard A. Mattano, Jr"><meta name="DC.Contributor" content="Naomi J. Winick"><meta name="DC.Contributor" content="Elaine R. Mardis"><meta name="DC.Contributor" content="Robert S. Fulton"><meta name="DC.Contributor" content="Deepa Bhojwani"><meta name="DC.Contributor" content="Scott C. Howard"><meta name="DC.Contributor" content="Sima Jeha"><meta name="DC.Contributor" content="Ching-Hon Pui"><meta name="DC.Contributor" content="Stephen P. Hunger"><meta name="DC.Contributor" content="William E. Evans"><meta name="DC.Contributor" content="Mignon L. Loh"><meta name="DC.Contributor" content="Mary V. Relling"><meta name="DC.Date" content="2016 Jun 20"><meta name="DC.Identifier" content="10.1200/JCO.2015.64.5812"><meta name="DC.Language" content="en"><meta property="og:title" content="Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia"><meta property="og:type" content="article"><meta property="og:description" content="Acute pancreatitis is one of the common causes of asparaginase intolerance. The mechanism is unknown, and genetic predisposition to asparaginase-induced pancreatitis has not been previously identified.To determine clinical risk factors for asparaginase-induced ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962704/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jco.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4962704/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4962704/pdf/JCO645812.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8A1BF6DD592E01000000000250015E.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962704%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22J Clin Oncol%22[journal]" class="navlink">J Clin Oncol</a></li><li class="accid">PMC4962704</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jco.gif" alt="Logo of jco" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,56,105,76" alt="Home" title="Home" href="http://jco.ascopubs.org" ref="reftype=publisher&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="104,56,258,76" alt="This Article" title="This Article" href="http://jco.ascopubs.org/cgi/content/full/34/18/2133" ref="reftype=publisher&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="0,0,157,57" href="http://jco.ascopubs.org/" ref="reftype=publisher&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="257,56,380,76" alt="Search" title="Search" href="http://jco.ascopubs.org/search.dtl" ref="reftype=publisher&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="379,56,500,77" alt="Submit" title="Submit" href="http://submit.jco.org/" ref="reftype=publisher&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="poly" coords="450,2,431,9,425,27,429,43,437,54,459,55,471,52,483,42,486,29,479,11,466,2,449,2" alt="ASCO JCO Homepage" title="ASCO JCO Homepage" href="http://jco.ascopubs.org" ref="reftype=publisher&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">J Clin Oncol</a></span>. 2016 Jun 20; 34(18): 2133–2140. </span></div><div><span class="fm-vol-iss-date">Published online 2016 Apr 25. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1200%2FJCO.2015.64.5812" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1200/JCO.2015.64.5812</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4962704</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/27114598">27114598</a></div></div></div></div><h1 class="content-title">Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Liu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355219712160" co-class="co-affbox">Chengcheng Liu</a>,<sup></sup> <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355289552464" co-class="co-affbox">Wenjian Yang</a>,<sup></sup> <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355219709664" co-class="co-affbox">Meenakshi Devidas</a>,<sup></sup> <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355253806624" co-class="co-affbox">Cheng Cheng</a>,<sup></sup> <a href="/pubmed/?term=Pei%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355253804768" co-class="co-affbox">Deqing Pei</a>,<sup></sup> <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355293022544" co-class="co-affbox">Colton Smith</a>,<sup></sup> <a href="/pubmed/?term=Carroll%20WL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355293020688" co-class="co-affbox">William L. Carroll</a>,<sup></sup> <a href="/pubmed/?term=Raetz%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355293018832" co-class="co-affbox">Elizabeth A. Raetz</a>,<sup></sup> <a href="/pubmed/?term=Bowman%20WP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355217631776" co-class="co-affbox">W. Paul Bowman</a>,<sup></sup> <a href="/pubmed/?term=Larsen%20EC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355217629920" co-class="co-affbox">Eric C. Larsen</a>,<sup></sup> <a href="/pubmed/?term=Maloney%20KW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355255901760" co-class="co-affbox">Kelly W. Maloney</a>,<sup></sup> <a href="/pubmed/?term=Martin%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355255899904" co-class="co-affbox">Paul L. Martin</a>,<sup></sup> <a href="/pubmed/?term=Mattano%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355214951136" co-class="co-affbox">Leonard A. Mattano, Jr</a>,<sup></sup> <a href="/pubmed/?term=Winick%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355214949024" co-class="co-affbox">Naomi J. Winick</a>,<sup></sup> <a href="/pubmed/?term=Mardis%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355214947168" co-class="co-affbox">Elaine R. Mardis</a>,<sup></sup> <a href="/pubmed/?term=Fulton%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355213494512" co-class="co-affbox">Robert S. Fulton</a>,<sup></sup> <a href="/pubmed/?term=Bhojwani%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355213492656" co-class="co-affbox">Deepa Bhojwani</a>,<sup></sup> <a href="/pubmed/?term=Howard%20SC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355289665776" co-class="co-affbox">Scott C. Howard</a>,<sup></sup> <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355289663920" co-class="co-affbox">Sima Jeha</a>,<sup></sup> <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355289662064" co-class="co-affbox">Ching-Hon Pui</a>,<sup></sup> <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355219642144" co-class="co-affbox">Stephen P. Hunger</a>,<sup></sup> <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355219640288" co-class="co-affbox">William E. Evans</a>,<sup></sup> <a href="/pubmed/?term=Loh%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355256085216" co-class="co-affbox">Mignon L. Loh</a>,<sup></sup> and  <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598" class="affpopup" co-rid="_co_idm140355256083360" co-class="co-affbox">Mary V. Relling</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup><sup></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140355219712160"><h3 class="no_margin">Chengcheng Liu</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Liu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Chengcheng Liu</a></div></div><div id="_co_idm140355289552464"><h3 class="no_margin">Wenjian Yang</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Wenjian Yang</a></div></div><div id="_co_idm140355219709664"><h3 class="no_margin">Meenakshi Devidas</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Meenakshi Devidas</a></div></div><div id="_co_idm140355253806624"><h3 class="no_margin">Cheng Cheng</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Cheng Cheng</a></div></div><div id="_co_idm140355253804768"><h3 class="no_margin">Deqing Pei</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Pei%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Deqing Pei</a></div></div><div id="_co_idm140355293022544"><h3 class="no_margin">Colton Smith</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Colton Smith</a></div></div><div id="_co_idm140355293020688"><h3 class="no_margin">William L. Carroll</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Carroll%20WL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">William L. Carroll</a></div></div><div id="_co_idm140355293018832"><h3 class="no_margin">Elizabeth A. Raetz</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Raetz%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Elizabeth A. Raetz</a></div></div><div id="_co_idm140355217631776"><h3 class="no_margin">W. Paul Bowman</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Bowman%20WP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">W. Paul Bowman</a></div></div><div id="_co_idm140355217629920"><h3 class="no_margin">Eric C. Larsen</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Larsen%20EC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Eric C. Larsen</a></div></div><div id="_co_idm140355255901760"><h3 class="no_margin">Kelly W. Maloney</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Maloney%20KW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Kelly W. Maloney</a></div></div><div id="_co_idm140355255899904"><h3 class="no_margin">Paul L. Martin</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Martin%20PL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Paul L. Martin</a></div></div><div id="_co_idm140355214951136"><h3 class="no_margin">Leonard A. Mattano, Jr</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Mattano%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Leonard A. Mattano, Jr</a></div></div><div id="_co_idm140355214949024"><h3 class="no_margin">Naomi J. Winick</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Winick%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Naomi J. Winick</a></div></div><div id="_co_idm140355214947168"><h3 class="no_margin">Elaine R. Mardis</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Mardis%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Elaine R. Mardis</a></div></div><div id="_co_idm140355213494512"><h3 class="no_margin">Robert S. Fulton</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Fulton%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Robert S. Fulton</a></div></div><div id="_co_idm140355213492656"><h3 class="no_margin">Deepa Bhojwani</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Bhojwani%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Deepa Bhojwani</a></div></div><div id="_co_idm140355289665776"><h3 class="no_margin">Scott C. Howard</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Howard%20SC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Scott C. Howard</a></div></div><div id="_co_idm140355289663920"><h3 class="no_margin">Sima Jeha</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Sima Jeha</a></div></div><div id="_co_idm140355289662064"><h3 class="no_margin">Ching-Hon Pui</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Ching-Hon Pui</a></div></div><div id="_co_idm140355219642144"><h3 class="no_margin">Stephen P. Hunger</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Stephen P. Hunger</a></div></div><div id="_co_idm140355219640288"><h3 class="no_margin">William E. Evans</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">William E. Evans</a></div></div><div id="_co_idm140355256085216"><h3 class="no_margin">Mignon L. Loh</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Loh%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Mignon L. Loh</a></div></div><div id="_co_idm140355256083360"><h3 class="no_margin">Mary V. Relling</h3><p>Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</p><div>Find articles by <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27114598">Mary V. Relling</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140355219423296_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140355219423296_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140355219423296_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en">Chengcheng Liu, Wenjian Yang, Cheng Cheng, Deqing Pei, Colton Smith, Sima Jeha, Ching-Hon Pui, William E. Evans, and Mary V. Relling, St Jude Children’s Research Hospital; Scott C. Howard, University of Memphis, Memphis, TN; Meenakshi Devidas, University of Florida, Gainesville, FL; William L. Carroll, New York University Langone Medical Center, New York, NY; Elizabeth A. Raetz, University of Utah, Salt Lake City, UT; W. Paul Bowman, Cook Children’s Hospital, Ft Worth; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; Eric C. Larsen, Maine Children’s Cancer Program, Scarborough, ME; Kelly W. Maloney, University of Colorado Denver, Aurora, CO; Paul L. Martin, Duke University, Durham, NC; Leonard A. Mattano Jr, HARP Pharma Consulting, Mystic, CT; Elaine R. Mardis and Robert S. Fulton, The McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO; Deepa Bhojwani, Children’s Hospital of Los Angeles, Los Angeles; Mignon L. Loh, University of California San Francisco Medical Center-Parnassus, San Francisco, CA; and Stephen P. Hunger, Children’s Hospital of Philadelphia, Philadelphia, PA.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div id="cor1">Corresponding author: Mary V. Relling, PharmD, St Jude Children’s Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105-2794; e-mail: <a href="mailto:dev@null" data-email="gro.edujts@gniller.yram" class="oemail">gro.edujts@gniller.yram</a>.</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140355219423296_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2016 by American Society of Clinical Oncology</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC4962704/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
Data Supplement
</div>

<div><a href="/pmc/articles/PMC4962704/bin/supp_34_18_2133__index.html" data-ga-action="click_feat_suppl">supp_34_18_2133__index.html</a><span style="color:gray"> (2.1K)</span></div><div class="small guid">GUID:&nbsp;3F78A3D0-57D7-4686-B909-9758FCB06316</div>
<div><a href="/pmc/articles/PMC4962704/bin/supp_JCO.2015.64.5812_DS_2015.645812.pdf" data-ga-action="click_feat_suppl">supp_JCO.2015.64.5812_DS_2015.645812.pdf</a><span style="color:gray"> (831K)</span></div><div class="small guid">GUID:&nbsp;62EF51D1-7A70-4798-A76C-C892F5EB5159</div>
</div></dd></dl></div><div id="idm140355217823152" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140355217823152title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Purpose</h3><p id="__p1" class="p p-first-last">Acute pancreatitis is one of the common causes of asparaginase intolerance. The mechanism is unknown, and genetic predisposition to asparaginase-induced pancreatitis has not been previously identified.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">To determine clinical risk factors for asparaginase-induced pancreatitis, we studied a cohort of 5,185 children and young adults with acute lymphoblastic leukemia, including 117 (2.3%) who were diagnosed with at least one episode of acute pancreatitis during therapy. A genome-wide association study was performed in the cohort and in an independent case-control group of 213 patients to identify genetic risk factors.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Risk factors associated with pancreatitis included genetically defined Native American ancestry (<em>P</em> &lt; .001), older age (<em>P</em> &lt; .001), and higher cumulative dose of asparaginase (<em>P</em> &lt; .001). No common variants reached genome-wide significance in the genome-wide association study, but a rare nonsense variant rs199695765 in <em>CPA2</em>, encoding carboxypeptidase A2, was highly associated with pancreatitis (hazard ratio, 587; 95% CI, 66.8 to 5166; <em>P</em> = 9.0 × 10<sup>−9</sup>). A gene-level analysis showed an excess of additional <em>CPA2</em> variants in patients who did versus those who did not develop pancreatitis (<em>P</em> = .001). Sixteen <em>CPA2</em> single-nucleotide polymorphisms were associated (<em>P</em> &lt; .05) with pancreatitis, and 13 of 24 patients who carried at least one of these variants developed pancreatitis. Biologic functions that were overrepresented by common variants modestly associated with pancreatitis included purine metabolism and cytoskeleton regulation.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">Older age, higher exposure to asparaginase, and higher Native American ancestry were independent risk factors for pancreatitis in patients with acute lymphoblastic leukemia. Those who inherit a nonsense rare variant in the <em>CPA2</em> gene had a markedly increased risk of asparaginase-induced pancreatitis.</p></div></div></div><div id="s1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s1title">INTRODUCTION</h2><p id="__p5" class="p p-first">Asparaginase is a major cause of pancreatitis that occurs in 2% to 18% of patients treated for acute lymphoblastic leukemia (ALL),<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250548">1</a>-<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250537">9</a></sup> although steroids and thiopurines can also cause this complication.<sup><a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250538">10</a>-<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250507">12</a></sup> Severe pancreatitis is a contraindication to further asparaginase therapy and has been associated with compromised treatment outcome.<sup><a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250513">3</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250521">7</a>,<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250496">13</a></sup> Better understanding the risk factors for pancreatitis could help improve ALL therapy by identifying mechanisms of pancreatitis, which might lead to new interventions to prevent or reverse it, or by identifying patients at such high risk that consideration of non–asparaginase-containing regimens would be warranted.</p><p id="__p6">The pathogenesis of asparaginase-induced pancreatitis has not been elucidated. Clinical risk factors include intensive asparaginase and older age<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250535">1</a>-<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250540">4</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250522">7</a>,<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250504">14</a>,<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250512">15</a></sup>; however, most studies lack sufficient power to robustly assess risk factors.<sup><a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250544">4</a>-<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250511">8</a></sup></p><p id="__p7" class="p p-last">Studies on pancreatitis of other etiologies, such as alcoholic pancreatitis, have identified a few genetic risk factors (eg, <em>PRSS1</em>, <em>PRSS2</em>, <em>SPINK1</em>, <em>CFTR</em>, <em>CTRC</em>, <em>CASR</em>, <em>CLDN2</em>, <em>CPA1</em>, and <em>HLA-DRB1</em>*07:01), most of which relate to premature trypsin activation or sustained trypsin activity in the pancreas.<sup><a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250524">16</a>-<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250529">23</a></sup> However, there has not been an agnostic genome-wide association study (GWAS) of asparaginase-induced acute pancreatitis.<sup><a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_702818162">24</a></sup> Here we report the largest study to date to determine the clinical and genetic risk factors for acute pancreatitis in 5,398 patients treated for newly diagnosed ALL with contemporary regimens containing asparaginase.</p></div><div id="s2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s2title">METHODS</h2><div id="s3" class="sec sec-first"><h3 id="s3title">Patients and Treatment</h3><p id="__p8" class="p p-first">We investigated patients (age 0 to 30 years) with newly diagnosed ALL treated on seven front-line protocols (<a href="/pmc/articles/PMC4962704/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>; Data Supplement Table 1): Total XIIIB (NCI-T93-0101D),<sup><a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250500">25</a></sup> Total XV (<a id="__tag_547250578" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00137111" ref="reftype=extlink-clinical-trial&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00137111","term_id":"NCT00137111"}}</span>NCT00137111</a>),<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250516">26</a></sup> COG P9904 (<a id="__tag_547250577" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005585" ref="reftype=extlink-clinical-trial&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005585","term_id":"NCT00005585"}}</span>NCT00005585</a>),<sup><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250506">27</a></sup> P9905 (<a id="__tag_547250579" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005596" ref="reftype=extlink-clinical-trial&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005596","term_id":"NCT00005596"}}</span>NCT00005596</a>),<sup><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250528">27</a></sup> P9906 (<a id="__tag_547250575" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00005603" ref="reftype=extlink-clinical-trial&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00005603","term_id":"NCT00005603"}}</span>NCT00005603</a>),<sup><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250501">27</a></sup> AALL0232 (<a id="__tag_547250576" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00075725" ref="reftype=extlink-clinical-trial&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00075725","term_id":"NCT00075725"}}</span>NCT00075725</a>),<sup><a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250523">28</a></sup> and AALL0331 (<a id="__tag_547250574" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00103285" ref="reftype=extlink-clinical-trial&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00103285","term_id":"NCT00103285"}}</span>NCT00103285</a>) at St Jude Children’s Research Hospital and in the Children’s Oncology Group.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4962704/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140355217597856" class="figure"><a href="/pmc/articles/PMC4962704/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4962704_JCO645812f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is JCO645812f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4962704/bin/JCO645812f1.jpg"></a></div><div id="largeobj_idm140355217597856" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4962704/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4962704/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig 1.</a></div><!--caption a7--><div class="caption"><p id="__p9">Study design and genotyping platforms of the initial genome-wide association study (5,398 patients) that aimed to identify the top-ranked single-nucleotide polymorphisms (SNPs) and genes from the cohort, and the SNPs or genes significantly associated with pancreatitis (<em>P</em> &lt; .05) in the case-control group. The number of patients and number of cases (in brackets) in each protocol are shown.</p></div></div></div><p id="__p10" class="p p-last">Among 5,958 patients enrolled on Total XIIIB/XV, COG P9904/P9905/P9906, and AALL0232, we studied 5,185 patients (including 117 cases) with available DNA (Data Supplement Table 2). There were 209 (4.0%) adolescents and young adults (age 18 to 30 years) in the cohort, and 3.6% (8 of 209) adolescents and young adults developed pancreatitis, making up 6.8% of the 117 cases. From approximately 5,500 patients enrolled in AALL0331, there were 103 cases of pancreatitis; of these, we included all 71 cases who had available germline DNA and successful genotyping and matched two controls to each case by age (± 2 years) and protocol-planned asparaginase doses. Patient characteristics by protocol are described in the Data Supplement Table 3. The studies were approved by the institutional review boards of all participating institutions. Informed consent was obtained in accordance with the Declaration of Helsinki.</p></div><div id="s4" class="sec"><h3 id="s4title">Diagnosis of Pancreatitis and Analysis of Clinical Risk Factors</h3><p id="__p11" class="p p-first-last">Acute pancreatitis was prospectively graded using the National Cancer Institute’s Common Terminology Criteria for Adverse Events version 3.0 for AALL0232 and AALL0331, and version 2.0 for all the other protocols. The criteria were similar across all studies, including symptoms (abdominal pain, nausea, and vomiting), increased serum amylase or lipase, and radiographic or surgical findings. Only symptomatic episodes (grade 3 and 4 for v2.0 and grade 2 to 4 for v3.0) were included in the analysis regardless of severity; there were no fatal (grade 5) cases. For time-dependent analyses, time to first episode of pancreatitis was considered if the patient had more than one episode. To identify covariates to include in the GWAS, we used the Fine-Gray regression model for competing risks<sup><a href="#B29" rid="B29" class=" bibr popnode">29</a></sup> to evaluate the association between pancreatitis and variables including age (in years) and genetic ancestry (as percentages of European, African, Asian, and Native American ancestries)<sup><a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250530">30</a></sup> as continuous variables; sex, ALL immunophenotype, and treatment regimen (protocol-planned cumulative asparaginase dose ≤ 120,000 U/m<sup>2</sup>
<em>v</em> ≥ 240,000 U/m<sup>2</sup>) were also included as categorical variables. Time at risk was censored at therapy completion; failures other than pancreatitis, such as induction failure, relapse, secondary malignancy, or death were considered as competing events. For purposes of normalizing asparaginase doses across protocols, pegylated <em>Escherichia coli</em>–asparaginase (PEG-asparaginase) at 2,500 U/m<sup>2</sup> every other week was considered equivalent to native <em>Escherichia coli</em>–asparaginase at 25,000 U/m<sup>2</sup> once per week for 2 weeks.</p></div><div id="s5" class="sec"><h3 id="s5title">Genotyping</h3><p id="__p12" class="p p-first-last">Genotyping of germline DNA was performed (<a href="/pmc/articles/PMC4962704/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig 1</span></a>; Data Supplement) for 5,398 patients with the Affymetrix Genome-Wide Human SNP 6.0 (or GeneChip Human Mapping 500K) Array (Santa Clara, CA) and 3,469 of the 5,398 with the Illumina HumanExome Beadchip Array (San Diego, CA). Genetic ancestries were determined using STRUCTURE<sup><a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250549">30</a></sup> and either treated as a continuous variable or used to categorize patients as white (European ancestry &gt; 90%), black (African ancestry &gt; 70%), Hispanic (Native American ancestry &gt; 10%, nonblack), Asian (Asian ancestry &gt; 90%), and other.</p></div><div id="s6" class="sec"><h3 id="s6title">Single-Nucleotide Polymorphism–Based Analysis for Pancreatitis</h3><p id="__p13" class="p p-first-last">After excluding single-nucleotide polymorphisms (SNPs) with low call rate, 751,455 SNPs on the SNP 6.0 and 169,521 SNPs on the Exome Beadchip were interrogated in the initial GWAS. Each SNP was tested using Gray’s test,<sup><a href="#B31" rid="B31" class=" bibr popnode">31</a></sup> and those achieving <em>P</em> &lt; .05 were subsequently analyzed. Genotype calls were coded as 0, 1, or 2 for the number of B alleles (AA, AB, or BB) assuming an additive genetic model. In the cohort (n = 5,185), further screening was performed using a Cox proportional hazards model analyzing the onset time of pancreatitis (time-dependent GWAS). Covariates included age, genetic ancestry, and treatment regimen as described above. Time to event was the length of time between the time at the first episode of pancreatitis and on-study time; for those without pancreatitis, time at risk was censored at therapy completion or at the time off treatment because of induction failure, relapse, secondary malignancy, or death. In the case-control group (n = 213), GWAS was performed using logistic regression, adjusted for genetic ancestry (time-independent GWAS).</p></div><div id="s7" class="sec"><h3 id="s7title">Gene-Level Analysis of Nonsense Variants Using Sequential Kernel Association Test</h3><p id="__p14" class="p p-first-last">SNPs were assigned to genes using Reference Sequence (Refseq) boundaries (UCSC Genome Browser [GRCh37/hg19] Assembly). For each gene, sequential kernel association test<sup><a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250539">32</a></sup> was applied to test for gene-level significance for nonsense variants. For time-dependent analysis, Martingale residuals from Cox proportional hazards model with demographic and clinical covariates were used as observations of a continuous phenotype in sequential kernel association test.</p></div><div id="s8" class="sec sec-last"><h3 id="s8title">Sequencing of Selected Genes</h3><p id="__p15" class="p p-first-last">To interrogate rare and low-frequency variants in genes of interest for ALL-related phenotypes, we sequenced 283 genes in 4,217 children in the cohort and 162 in the case-control group. The 283 genes were candidate genes for a number of ALL phenotypes (eg, relapse, drug sensitivity, pharmacokinetics, leukemia risk, and several adverse effects); 42 of these were possible pancreatitis risk genes (Data Supplement Table 4). Gene-level analysis of all 283 genes and SNP-based analysis of 9,229 SNPs in the 42 pancreatitis-associated genes was performed using the same methods as in the initial GWAS (Data Supplement).</p></div></div><div id="s9" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s9title">RESULTS</h2><div id="s10" class="sec sec-first"><h3 id="s10title">Pancreatitis Associated With Asparaginase</h3><p id="__p16" class="p p-first">Among the 5,185 patients in the cohort, 117 were diagnosed with at least one episode of pancreatitis during therapy, with these crude rates by protocol: Total XIIIB (0.9%, two of 222), Total XV (3.3%, 16 of 483), P9904 (0.7%, five of 717), P9905 (0.8%, seven of 888), P9906 (5.0%, 11 of 222), and AALL0232 (2.9%, 76 of 2,653). The cumulative incidence of pancreatitis by protocol is shown in <a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a>, accounting for time at risk and competing events.<sup><a href="#B29" rid="B29" class=" bibr popnode">29</a></sup> The first episode occurred at a median of 106 days from ALL diagnosis and developed during remission induction (first 4 to 6 weeks of treatment) in 24 of 117 (20.5%) patients or during the first year of therapy (including remission induction) in 104 of 117 (88.9%) patients. The great majority of the events were clustered with asparaginase administration (Data Supplement Figure 1). Among the 71 patients developing pancreatitis on AALL0331 (case-control group), the first episode occurred at a median of 78 days and developed during remission induction in 24 of 71 (33.8%) cases and during the first year in 65 of 71 (91.5%) cases.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140355251276608" class="figure"><a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4962704_JCO645812f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is JCO645812f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4962704/bin/JCO645812f2.jpg"></a></div><div id="largeobj_idm140355251276608" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4962704/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4962704/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig 2.</a></div><!--caption a7--><div class="caption"><p id="__p17">Incidence of pancreatitis differed by protocols. (A) Cumulative incidence estimates<sup><a href="#B29" rid="B29" class=" bibr popnode">29</a></sup> of pancreatitis in the cohort (N = 5,185) accounting for competing risks and time at risk by different protocols. Time at risk was censored at therapy completion; failures other than pancreatitis, such as induction failure, relapse, secondary malignancy, or death, are considered as competing events. The inset table shows the number of patients at risk at 0, 1, 2, and 2.5 years into therapy. (B) The relationship between the crude rates of pancreatitis and protocol-planned dose of asparaginase (ASP), and (C) the relationship between the crude rates of pancreatitis and protocol-planned treatment duration of ASP in this study (solid circles) and in some recently reported protocols<sup><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250505">2</a>-<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250533">4</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250514">6</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250543">7</a>,<a href="#B33" rid="B33" class=" bibr popnode">33</a>,<a href="#B34" rid="B34" class=" bibr popnode">34</a></sup> (open circles). These rates do not account for competing events or time at risk and are not incidences. The individual points show the average protocol-planned dose or treatment duration of native <em>Escherichia coli</em>–ASP across all treatment arms for each protocol. PEG-ASP 2,500 U/m<sup>2</sup> every other week is considered equivalent to native <em>E coli</em>-ASP at 25,000 U/m<sup>2</sup> once per week for 2 weeks. The linear regression lines, <em>R</em><sup>2</sup>, and <em>P</em> values are shown. PEG-ASP, pegylated <em>Escherichia coli</em>–asparaginase.</p></div></div></div><p id="__p18" class="p p-last">Considering the data herein and also prior publications of other front-line ALL protocols,<sup><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250550">2</a>-<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250497">4</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250503">6</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250520">7</a>,<a href="#B33" rid="B33" class=" bibr popnode">33</a>,<a href="#B34" rid="B34" class=" bibr popnode">34</a></sup> the crude rate of pancreatitis was related to cumulative asparaginase dose (<em>R</em><sup>2</sup>, 0.75; <em>P</em> &lt; .001) and duration of asparaginase treatment (<em>R</em><sup>2</sup>, 0.83; <em>P</em> &lt; .001; <a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figs 2B</span></a> and <a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2C).</span></span><span>2C</span></a>). Because asparaginase dose and duration were correlated (<em>R</em><sup>2</sup>, 0.64; <em>P</em> = .0011; Data Supplement Figure 2), it was not possible to determine which was more important for pancreatitis risk.</p></div><div id="s11" class="sec"><h3 id="s11title">Clinical Risk Factors</h3><p id="__p19" class="p p-first">A multivariate model revealed that older age (hazard ratio [HR], 1.1 per year; <em>P</em> &lt; .001) and genetically defined Native American ancestry (HR, 1.2 for every 10% increase in Native American ancestry; <em>P</em> &lt; .001) were associated with pancreatitis (<a href="/pmc/articles/PMC4962704/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). High-dose asparaginase regimens (≥ 240,000 U/m<sup>2</sup>) were associated with more pancreatitis (HR, 3.2; <em>P</em> &lt; .001). Patients who received PEG-asparaginase alone did not have significantly more pancreatitis than those who received the native formulation (<em>P</em> = .11), but formulation was not the only variable that differed among protocols. Because the number of Asian patients was relatively small (n = 99), we repeated the multivariate analysis (as shown in <a href="/pmc/articles/PMC4962704/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>) excluding Asian ancestry, and the prognostic importance of the other variables did not change (data not shown). To minimize the effect of dose as a confounder for evaluating formulation, we looked at P9904/P9905, the only study that included patients treated with one or the other formulation (Data Supplement Table 3), and the crude percentage with pancreatitis did not differ between those who received native asparaginase alone (0.8%, six of 723), PEG-asparaginase alone (0.9%, three of 347), or both (0.6%, three of 535). There was a positive linear relationship between the percentage of Native American ancestry and the crude rate of pancreatitis (<em>R</em><sup>2</sup>, 0.70; <em>P</em> = .0024; Data Supplement Figure 3). The univariate analysis (Data Supplement Table 5) and the classification and regression tree analysis (Data Supplement Figure 4) also depict the same clinical risk factors. Thus we used age, ancestry, and treatment regimen as covariates in the cohort and ancestry in the case-control group.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p20">Multivariate Analysis for Factors Associated With Pancreatitis in the Cohort Study (N = 5,185)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140355251056320" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th scope="col" rowspan="1" colspan="1" valign="top" align="center">Patient Characteristic</th><th scope="col" rowspan="1" colspan="1" valign="top" align="center"><em>P</em></th><th scope="col" rowspan="1" colspan="1" valign="top" align="center">HR (95% CI)</th></tr></thead><tbody><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">Native American ancestry (for every 10% interval)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt; .001</td><td rowspan="1" colspan="1" valign="top" align="center">1.2 (1.1 to 1.3)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">Age (per year)</td><td rowspan="1" colspan="1" valign="top" align="center">&lt; .001</td><td rowspan="1" colspan="1" valign="top" align="center">1.1 (1.0 to 1.2)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">High-dose ASP regimen*</td><td rowspan="1" colspan="1" valign="top" align="center">&lt; .001</td><td rowspan="1" colspan="1" valign="top" align="center">3.2 (1.7 to 5.9)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">African ancestry (for every 10% interval)</td><td rowspan="1" colspan="1" valign="top" align="center">.059</td><td rowspan="1" colspan="1" valign="top" align="center">1.1 (0.997 to 1.2)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">Native <em>Escherichia coli</em>–ASP only</td><td rowspan="1" colspan="1" valign="top" align="center">.11</td><td rowspan="1" colspan="1" valign="top" align="center">1.4 (0.9 to 2.2)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">T-cell lineage ALL</td><td rowspan="1" colspan="1" valign="top" align="center">.28</td><td rowspan="1" colspan="1" valign="top" align="center">1.7 (0.7 to 4.5)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">Asian ancestry (for every 10% interval)</td><td rowspan="1" colspan="1" valign="top" align="center">.55</td><td rowspan="1" colspan="1" valign="top" align="center">1.03 (0.9 to 1.2)</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left">Male sex</td><td rowspan="1" colspan="1" valign="top" align="center">.70</td><td rowspan="1" colspan="1" valign="top" align="center">1.1 (0.7 to 1.6)</td></tr></tbody></table></div><div id="largeobj_idm140355251056320" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4962704/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140355289229632"><p id="__p21" class="p p-first-last">NOTE. Association with risk of pancreatitis was assessed using the Fine-Gray regression model for competing risks. Age and ancestry were treated as continuous variables (eg, an HR of 1.2 suggests 1.2-fold higher risk of pancreatitis for every 10% increase in Native American ancestry). Other characteristic features are dichotomized for presence <em>v</em> absence of the indicated feature.</p></div><div id="idm140355289227776"><p id="__p22" class="p p-first-last">Abbreviations: ALL, acute lymphoblastic leukemia; ASP, asparaginase; HR, hazard ratio.</p></div><div id="t1n1"><sup>*</sup>Total protocol-specified <em>Escherichia coli</em>–ASP dose ≥ 240,000 U/m<sup>2</sup> (ie, all patients on Total XV, COG P9906, and AALL0232) compared with ≤ 120,000 U/m<sup>2</sup>.</div></div></div></div><div id="s12" class="sec"><h3 id="s12title">Gene-Level Analysis of Nonsense Variants Identified <em>CPA2</em></h3><p id="__p24" class="p p-first">Focusing on rare variants and nonsense variants, six genes were associated with pancreatitis in the cohort at <em>P</em> &lt; .05 and in the case-control group (<a href="/pmc/articles/PMC4962704/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). In the cohort, <em>CPA2</em>, with a nonsense SNP (rs199695765 C&gt;T) showed the strongest association (<em>P</em> = 2.1 × 10<sup>−9</sup>). This SNP was predicted to cause early termination of the CPA2 protein (<a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3A</span></a>). Two of 3,469 patients carried this variant (one in the cohort and one in the case-control group), and both developed early pancreatitis (<a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3B</span></a>); one of them had recurrent episodes after each of two asparaginase re-exposures.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p25">Six Genes Associated With Pancreatitis From the Gene-Level Analysis of Nonsense SNPs</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140355289181856" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" scope="col" colspan="1" valign="bottom" align="center">Gene</th><th rowspan="2" scope="col" colspan="1" valign="bottom" align="center">Chr</th><th rowspan="2" scope="col" colspan="1" valign="bottom" align="center">Nonsense SNPs</th><th rowspan="2" scope="col" colspan="1" valign="bottom" align="center">Major Allele/Risk Allele</th><th rowspan="2" scope="col" colspan="1" valign="bottom" align="center">Population RAF% of Nonsense SNP (No.)<sup>*</sup></th><th colspan="4" scope="colgroup" rowspan="1" valign="bottom" align="center">Cohort (n = 3,256) </th><th colspan="4" scope="colgroup" rowspan="1" valign="bottom" align="center">Case-Control (n = 213)</th><th rowspan="2" scope="col" colspan="1" valign="bottom" align="center">PPV/NPV<sup>§</sup> (N = 3,469)</th></tr><tr><th colspan="1" scope="colgroup" rowspan="1" valign="bottom" align="center">RAF % in Patients With Pancreatitis (n = 95)</th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center">RAF % in Patients Without Pancreatitis (n = 3,161)</th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center">Coefficient<sup>†</sup> (SE)</th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center"><em>SKAT P</em><sup>†</sup></th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center">RAF % in Cases (n = 71)</th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center">RAF % in Controls (n = 142)</th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center">Coefficient<sup>‡</sup> (SE)</th><th scope="col" rowspan="1" colspan="1" valign="bottom" align="center"><em>SKAT P</em><sup>‡</sup></th></tr></thead><tbody><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left"><em>CPA2</em></td><td rowspan="1" colspan="1" valign="top" align="center">7</td><td rowspan="1" colspan="1" valign="top" align="center">rs199695765</td><td rowspan="1" colspan="1" valign="top" align="center">C/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.009 (11)</td><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">6.5 (1.1)</td><td rowspan="1" colspan="1" valign="top" align="center">2.1 × 10<sup>−9</sup></td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">15.8 (7.4)</td><td rowspan="1" colspan="1" valign="top" align="center">.03</td><td rowspan="1" colspan="1" valign="top" align="center">100/95.6</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left"><em>SERPINA9</em></td><td rowspan="1" colspan="1" valign="top" align="center">14</td><td rowspan="1" colspan="1" valign="top" align="center">rs78283108</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.6 (732)</td><td rowspan="1" colspan="1" valign="top" align="center">2.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">1.2 (0.4)</td><td rowspan="1" colspan="1" valign="top" align="center">.006</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">16.2 (6.7)</td><td rowspan="1" colspan="1" valign="top" align="center">.02</td><td rowspan="1" colspan="1" valign="top" align="center">11.5/95.6</td></tr><tr><td rowspan="2" scope="row" colspan="1" valign="top" align="left"><em>HSD17B2</em></td><td rowspan="2" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center">rs8191246</td><td rowspan="1" colspan="1" valign="top" align="center">A/G</td><td rowspan="1" colspan="1" valign="top" align="center">1.4 (1,557)</td><td rowspan="1" colspan="1" valign="top" align="center">3.3</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="2" colspan="1" valign="top" align="center">1.5 (0.5)</td><td rowspan="2" colspan="1" valign="top" align="center">.006</td><td rowspan="1" colspan="1" valign="top" align="center">3.4</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="2" colspan="1" valign="top" align="center">17.1 (5.9)</td><td rowspan="2" colspan="1" valign="top" align="center">.004</td><td rowspan="1" colspan="1" valign="top" align="center">17.2/95.7</td></tr><tr><td colspan="1" scope="row" rowspan="1" valign="top" align="center">rs200540657</td><td rowspan="1" colspan="1" valign="top" align="center">T/G</td><td rowspan="1" colspan="1" valign="top" align="center">0.001 (1)</td><td rowspan="1" colspan="1" valign="top" align="center">0.1</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td colspan="1" rowspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td colspan="1" rowspan="1" valign="top" align="center">0/94.8</td></tr><tr><td scope="row" rowspan="1" colspan="1" valign="top" align="left"><em>GCKR</em></td><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center">rs146053779</td><td rowspan="1" colspan="1" valign="top" align="center">C/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.09 (111)</td><td rowspan="1" colspan="1" valign="top" align="center">1.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.3</td><td rowspan="1" colspan="1" valign="top" align="center">1.7 (0.7)</td><td rowspan="1" colspan="1" valign="top" align="center">.015</td><td rowspan="1" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">15.4 (8.5)</td><td rowspan="1" colspan="1" valign="top" align="center">.07</td><td rowspan="1" colspan="1" valign="top" align="center">16.7/95.6</td></tr><tr><td rowspan="2" scope="row" colspan="1" valign="top" align="left"><em>ZNF233</em></td><td rowspan="2" colspan="1" valign="top" align="center">19</td><td rowspan="1" colspan="1" valign="top" align="center">rs144014948</td><td rowspan="1" colspan="1" valign="top" align="center">G/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.09 (112)</td><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.1</td><td rowspan="2" colspan="1" valign="top" align="center">1.9 (0.8)</td><td rowspan="2" colspan="1" valign="top" align="center">.019</td><td rowspan="2" colspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="2" colspan="1" valign="top" align="center">15.5 (8.3)</td><td rowspan="2" colspan="1" valign="top" align="center">.06</td><td rowspan="1" colspan="1" valign="top" align="center">25.0/95.6</td></tr><tr><td colspan="1" scope="row" rowspan="1" valign="top" align="center">rs148348903</td><td rowspan="1" colspan="1" valign="top" align="center">T/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.09 (114)</td><td rowspan="1" colspan="1" valign="top" align="center">1.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.1</td><td colspan="1" rowspan="1" valign="top" align="center">0</td><td colspan="1" rowspan="1" valign="top" align="center">20.0/95.6</td></tr><tr><td rowspan="2" scope="row" colspan="1" valign="top" align="left"><em>SLC6A18</em></td><td rowspan="2" colspan="1" valign="top" align="center">5</td><td rowspan="1" colspan="1" valign="top" align="center">rs143864547</td><td rowspan="1" colspan="1" valign="top" align="center">C/A</td><td rowspan="1" colspan="1" valign="top" align="center">0.003 (4)</td><td rowspan="1" colspan="1" valign="top" align="center">0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.02</td><td rowspan="2" colspan="1" valign="top" align="center">5.0 (2.3)</td><td rowspan="2" colspan="1" valign="top" align="center">.028</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="2" colspan="1" valign="top" align="center">16.0 (7.4)</td><td rowspan="2" colspan="1" valign="top" align="center">.03</td><td rowspan="1" colspan="1" valign="top" align="center">50.0/95.6</td></tr><tr><td colspan="1" scope="row" rowspan="1" valign="top" align="center">rs200802505</td><td rowspan="1" colspan="1" valign="top" align="center">C/T</td><td rowspan="1" colspan="1" valign="top" align="center">0.03 (41)</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td rowspan="1" colspan="1" valign="top" align="center">0.08</td><td colspan="1" rowspan="1" valign="top" align="center">0.8</td><td rowspan="1" colspan="1" valign="top" align="center">0</td><td colspan="1" rowspan="1" valign="top" align="center">20.0/95.5</td></tr></tbody></table></div><div id="largeobj_idm140355289181856" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4962704/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140355214204864"><p id="__p26" class="p p-first-last">NOTE. The genes were rank ordered by SKAT <em>P</em> value in the cohort study, and then filtered by the direction in the case-control study. Only patients with exome array data are included in this analysis of nonsense SNPs.</p></div><div id="idm140355214203184"><p id="__p27" class="p p-first-last">Abbreviations: chr, chromosome; NPV, negative predictive value; PPV, positive predictive value; RAF, risk allele frequency; SKAT, sequential kernel association test; SNP, single-nucleotide polymorphism.</p></div><div id="t2n1"><sup>*</sup>Population risk allele frequency and number of carriers of the nonsense SNP on the basis of the ExAC data set<sup><a href="#B35" rid="B35" class=" bibr popnode">35</a></sup> of 61,486 unrelated individuals of European, African, Latino, and Asian origins.</div><div id="t2n2"><sup>†</sup>Coefficient, SE, and <em>P</em> value were estimated using Cox proportional hazard model after collapsing all nonsense SNPs.</div><div id="t2n3"><sup>‡</sup>Coefficient, SE, and <em>P</em> value were estimated using logistic regression model after collapsing all nonsense SNPs.</div><div id="t2n4"><sup>§</sup>PPV = (number of patients who carried the nonsense SNP and developed pancreatitis)/(number of patients who carried the nonsense SNP). NPV = (number of patients who did not carry the nonsense SNP or develop pancreatitis)/(number of patients who did not carry the nonsense SNP). The number of patients from the cohort and the case-control group were combined.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140355251259872" class="figure"><a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4962704_JCO645812f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is JCO645812f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4962704/bin/JCO645812f3.jpg"></a></div><div id="largeobj_idm140355251259872" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4962704/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC4962704/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Fig 3.</a></div><!--caption a7--><div class="caption"><p id="__p32">Nonsense single-nucleotide polymorphism (SNP) rs199695765 in <em>CPA2</em> associated with pancreatitis. (A) Protein structure of proCPA2 (without the 16–amino acid signal peptide) with the nonsense SNP rs199695765 (arrow) located in the propeptide domain. The unaffected region of p.Q51X variant (magenta), the affected propeptide (yellow), and the active enzyme moiety (blue) are shown. (B) Cumulative incidence of pancreatitis in patients in the cohort or in the case-control group who carried any <em>CPA2</em> nonsense or missense SNPs (variant) was higher than that in patients who are classified as wild type (ie, they carried no or only synonymous or noncoding SNPs). *<em>P</em> = .001 using the Fine-Gray competing risks regression after adjusting for clinical characteristics.</p></div></div></div></div><div id="s13" class="sec"><h3 id="s13title">GWAS of Common SNPs</h3><p id="__p33" class="p p-first-last">Analyzing all coding and noncoding common SNPs (minor allele frequency [MAF] ≥ 1%) in the cohort, we identified loci in a purine metabolism gene, <em>FHIT</em> (rs9849262; <em>P</em> = 8.4 × 10<sup>−6</sup>). Among the top 20 common SNPs, 14 were assigned to seven genes, and seven of the 14 SNPs were in three genes involved in cytoskeleton regulation, including <em>DOCK5</em>, <em>ACTN2</em>, and <em>MICAL2</em> (Data Supplement Table 6). These SNPs were also associated with pancreatitis in the case-control study, although some did not reach <em>P</em> &lt; .05 in this relatively small group. Results for top-ranked variants from single SNP analyses, including nonsense, missense, synonymous, and noncoding SNPs, are shown in the Data Supplement Tables 7, 8, and 9.</p></div><div id="s14" class="sec sec-last"><h3 id="s14title">Sequencing Detected Novel Variants in <em>CPA2</em> and Other Candidate Genes</h3><p id="__p34" class="p p-first">We identified additional variants by sequencing 283 genes, 42 of which were a priori classified as likely candidate genes for pancreatitis on the basis of our GWAS results (n = 34) or on prior links to pancreatitis in other settings (n = 8; <em>PRSS1</em>, <em>PRSS2</em>, <em>SPINK1</em>, <em>CFTR</em>, <em>CASR</em>, <em>CTRC</em>, <em>CPA1</em>, <em>CLDN2</em>; Data Supplement Table 4).</p><p id="__p35">For the 4,217 children in the cohort and 162 in the case-control group with sequencing data, 380 variants were identified in <em>CPA2</em>, and 16 were associated with pancreatitis (Data Supplement Table 10). Thirteen of 24 (54%) patients who carried at least one of these variants developed pancreatitis. Interestingly, two of three patients who had three episodes carried one of these <em>CPA2</em> variants (rs199695765 and an intronic SNP chr7:129915817G&gt;A). Patients carrying <em>CPA2</em> coding variants had more pancreatitis than those without any coding variants (HR, 2.4; 95% CI, 1.2 to 5.1; <em>P</em> = .001) after adjusting for clinical features (<a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3B</span></a>). For patients who carried the nonsense SNP rs199695765, the estimated increased risk was high (HR, 587; 95% CI, 66.8 to 5,166; <em>P</em> = 9.0 × 10<sup>−9</sup>). The positive and negative predictive values of rs199695765 were 100% (95% CI, 19.3% to 100%) and 95.6% (95% CI, 94.8% to 96.2%). Of 61,486 subjects in the Exome Aggregation Consortium (ExAC) data set,<sup><a href="#B35" rid="B35" class=" bibr popnode">35</a></sup> 11 individuals were heterozygous for this variant, yielding an allele frequency in the general population of only 0.009% (<a href="/pmc/articles/PMC4962704/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p><p id="__p36">Similar to the initial GWAS, we conducted a gene-level analysis of nonsense variants in the 42 putative pancreatitis genes versus the 241 nonpancreatitis genes (Data Supplement Table 11). On the basis of sequencing, a higher proportion of putative candidate pancreatitis genes had associations than the noncandidate genes at <em>P</em> &lt; .05 (16 of 42 <em>v</em> five of 241; <em>P</em> &lt; .001). In the gene-level analysis, <em>HOGA1</em> with a nonsense SNP (chr10:99361676 C&gt;T, p.R255X) showed the strongest association in the cohort (<em>P</em> = 6.4 × 10<sup>−11</sup>). The only patient heterozygous for this nonsense variant developed pancreatitis early, at day 17. <em>CPA2</em> ranked second (for nonsense SNPs; <em>P</em> = 6.7 × 10<sup>−11</sup>) and remained significant when the gene-based analysis included any missense (<em>P</em> = 5.5 × 10<sup>−3</sup>) or any coding variants (<em>P</em> = .045).</p><p id="__p37" class="p p-last">Among the eight candidate genes previously associated with pancreatitis in other settings, 1,732 coding polymorphisms were identified via sequencing (Data Supplement Table 12). Eighty-one SNPs were associated at the <em>P</em> &lt; .05 level in either the cohort or the case-control group, but none of them were significant in both groups. A variant (chr7:117119516G&gt;A) upstream of <em>CFTR</em> showed the strongest association in the cohort (<em>P</em> = 4.4 × 10<sup>−9</sup>); this variant was carried by only one patient, who developed early pancreatitis at day 25. None of these candidate genes were associated with pancreatitis in the gene-level analysis.</p></div></div><div id="s15" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s15title">DISCUSSION</h2><p id="__p38" class="p p-first">Acute pancreatitis is a serious complication of asparaginase and can limit the ability to deliver curative chemotherapy. The pathogenesis and mechanisms remain unknown, and it has not been possible to identify patients at risk a priori. There is no specific treatment of acute pancreatitis; only supportive care is given.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_716729008">36</a></sup> Thus, the genetic and nongenetic risk factors we discovered in this largest study to date may have importance for understanding the mechanisms and developing targeted interventions for patients with predisposition to pancreatitis.</p><p id="__p39">Variants in <em>CPA2</em> (carboxypeptidase A2) were associated with risk of pancreatitis in patients with ALL. This gene encodes a 417–amino acid proenzyme (proCPA2).<sup><a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250502">37</a></sup> The high-risk variant we identified is a nonsense SNP (rs199695765) in exon 2, resulting in early termination in the propeptide region (<a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3A</span></a>). Among 4,379 patients, the two who carried this variant developed severe pancreatitis within weeks of their first dose of asparaginase (<a href="/pmc/articles/PMC4962704/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig 3B</span></a>), suggesting asparaginase will not be tolerated long enough to be effective in patients who inherit this rare variant. It is unclear whether the MAF (0.023%) in this ALL cohort was comparable to or higher than the MAF in the general population (0.009%), but in any case, it is rare. In addition to rs199695765, there were 15 other variants in <em>CPA2</em> associated with pancreatitis (Data Supplement Table 10). The 16 variants were carried by 24 of 4,379 patients (collective MAF, 0.6%), and all 10 patients who carried the top 10 <em>CPA2</em> variants developed pancreatitis. These data suggest that <em>CPA2</em> variant carriers are at high risk of pancreatitis if treated with asparaginase. ALL treatment regimens vary substantially in the amount of asparaginase they include; an ALL treatment regimen that does not depend heavily on asparaginase may be preferable for these rare individuals.</p><p id="__p40">The underlying mechanism by which <em>CPA2</em> variants increase risk of pancreatitis is unclear. Pancreatic carboxypeptidases are secreted from acinar cells as proenzymes, then cleaved and activated by trypsin in the duodenum. Interestingly, patients heterozygous for functionally impaired variants in a related isoform, <em>CPA1</em>, are at higher risk of chronic pancreatitis.<sup><a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250532">38</a></sup></p><p id="__p41">The top-ranked gene on the basis of sequencing of 283 pharmacogenomic candidate genes was <em>HOGA1</em>, which catalyzes the breakdown of hydroxyproline.<sup><a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250518">39</a></sup> Only one patient of 4,379 studied carried the <em>HOGA1</em> nonsense variant. Reduced activity of HOGA1 may cause calcium oxalate urolithiasis<sup><a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250531">40</a></sup>; perhaps a similar excess of oxalate could lead to pancreatitis, because pancreas is a potential site of hydroxyproline degradation.<sup><a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250519">41</a></sup></p><p id="__p42">Although variants in <em>CPA2</em> and <em>HOGA1</em> were rare, the GWAS of common variants (Data Supplement Table 6) provided insights into other possible mechanisms. The lead gene <em>FHIT</em> is involved in purine metabolism.<sup><a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250527">39</a></sup> Because thiopurines are essential to ALL therapy and can also induce acute pancreatitis,<sup><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250545">11</a>,<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250509">12</a></sup> this finding may link thiopurines to some cases of pancreatitis in our study. Other top genes (<em>DOCK5</em>, <em>ACTN2</em>, and <em>MICAL2</em>) clustered in cytoskeleton function, supporting the hypothesis that cytoskeleton disruption may be involved in pancreatitis.<sup><a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250526">42</a>,<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250546">43</a></sup> Indeed cerulein, causing cytoskeleton disorganization, is used to initiate pancreatitis in animal models.<sup><a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250551">44</a></sup></p><p id="__p43">In this study, SNPs in the genes associated with non–drug-induced pancreatitis were not as strongly associated as the variants discovered using a GWAS agnostic approach (Data Supplement Table 12). Using gene-based approaches, none of these eight genes were among those with <em>P</em> &lt; .05 (Data Supplement Table 11). <em>HLA-DRB1*07:01</em> (tagged by rs17885382) has been associated with thiopurine-induced pancreatitis,<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_787947871">22</a></sup> but it was not associated with pancreatitis in our study (<em>P</em> = .1). These findings suggest different mechanisms of asparaginase-induced versus other forms of pancreatitis. That asparaginase-induced pancreatitis seems dose dependent (<a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig 2</span></a>), whereas thiopurine-induced pancreatitis does not,<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_787947872">22</a></sup> also suggests different pathogenesis caused by these two antileukemic drugs.</p><p id="__p44">Consistent with previous reports,<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250495">1</a>-<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250515">3</a>,<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250508">15</a>,<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250517">45</a></sup> older age was associated with pancreatitis in our study. Although steroids and thiopurines can cause pancreatitis, asparaginase is most likely the cause in the majority of our patients, because of its early onset (coinciding with asparaginase; Data Supplement Figure 1) and its relationship to asparaginase dose and duration<sup><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250525">2</a>-<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250499">4</a>,<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250541">6</a>,<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250536">7</a>,<a href="#B34" rid="B34" class=" bibr popnode">34</a>,<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_547250498">43</a></sup> (<a href="/pmc/articles/PMC4962704/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figs 2B and 2C</span></a>). The association with genetically defined ancestry is consistent with an important contribution of genetics in the development of pancreatitis (<a href="/pmc/articles/PMC4962704/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>; Data Supplement Figures 3 and 4); for example, risk alleles for 16 of the top 20 common variants (Data Supplement Table 6) were present at a higher frequency (at <em>P</em> &lt; .05) in the Hispanic- and African-ancestry groups than in others.</p><p id="__p45" class="p p-last">In summary, we showed older age, higher exposure to asparaginase, and higher Native American ancestry were independent risk factors for pancreatitis during ALL treatment. Rare nonsynonymous variants in <em>CPA2</em> were highly penetrant, and more common variants in genes critical to purine metabolism and cytoskeleton function were also associated with development of pancreatitis. Our findings are consistent with a mixed genetic architecture underlying serious adverse drug effects, wherein a combination of rare but highly penetrant and common but weakly penetrant genetic risk factors contribute to genetic predisposition. For the small number of patients carrying the highly penetrant <em>CPA2</em> variants, a precision medicine approach using ALL regimens containing less asparaginase should be considered.</p></div><div id="__sec5" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">

<!--caption a9--><strong>Data Supplement:</strong>

<div class="sup-box half_rhythm" id="idm140355219658160"><a href="/pmc/articles/PMC4962704/bin/supp_34_18_2133__index.html" data-ga-action="click_feat_suppl">Click here to view.</a></div>

</div></div><div id="idm140355219654624" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140355219654624title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn1"></p><p id="__p46" class="p p-first-last">Supported by grants GM 92666, CA 21765, CA 142665, CA 36401, P50 GM 115279, U10 CA98543 (Children’s Oncology Group [COG] Chair’s grant), U10 CA98413 (COG Statistical Center), and U24 CA114766 (COG Specimen Banking) from the National Cancer Institute; and by the American Lebanese Syrian Associated Charities.</p><p></p><p class="fn sec" id="fn2"> </p><p id="__p47" class="p p-first-last">Authors’ disclosures of potential conflicts of interest are found in the article online at <a href="http://www.jco.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.jco.org</a>. Author contributions are found at the end of this article.</p><p></p></div></div><div id="s17" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s17title">AUTHOR CONTRIBUTIONS</h2><!--/article/back/sec/--><p id="__p48" class="p p-first"><strong>Conception and design:</strong> Meenakshi Devidas, Cheng Cheng, Elizabeth A. Raetz, Stephen P. Hunger, Mary V. Relling</p><p id="__p49"><strong>Financial support:</strong> Stephen P. Hunger, William E. Evans, Mary V. Relling</p><p id="__p50"><strong>Provision of study materials or patients:</strong> Sima Jeha, Ching-Hon Pui, Stephen P. Hunger</p><p id="__p51"><strong>Collection and assembly of data:</strong> Wenjian Yang, Meenakshi Devidas, Colton Smith, William L. Carroll, W. Paul Bowman, Eric C. Larsen, Kelly W. Maloney, Paul L. Martin, Leonard A. Mattano Jr, Naomi J. Winick, Elaine R. Mardis, Robert S. Fulton, Scott C. Howard, Sima Jeha, Ching-Hon Pui, Stephen P. Hunger, Mignon L. Loh, Mary V. Relling</p><p id="__p52"><strong>Data analysis and interpretation:</strong> Chengcheng Liu, Wenjian Yang, Meenakshi Devidas, Cheng Cheng, Deqing Pei, Leonard A. Mattano Jr, Deepa Bhojwani, Ching-Hon Pui, William E. Evans, Mary V. Relling</p><p id="__p53"><strong>Manuscript writing:</strong> All authors</p><p id="__p54" class="p p-last"><strong>Final approval of manuscript:</strong> All authors</p></div><div id="s18" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s18title">AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</h2><!--/article/back/sec/--><div id="s19" class="sec sec-first"><h3 id="s19title">Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia</h3><p id="__p55" class="p p-first-last">The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to <a href="http://www.asco.org/rwc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.asco.org/rwc</a> or <a href="http://jco.ascopubs.org/site/ifc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">jco.ascopubs.org/site/ifc</a>.</p></div><div id="s20" class="sec"><h3 id="s20title">Chengcheng Liu</h3><p id="__p56" class="p p-first-last">No relationship to disclose</p></div><div id="s21" class="sec"><h3 id="s21title">Wenjian Yang</h3><p id="__p57" class="p p-first-last">No relationship to disclose</p></div><div id="s22" class="sec"><h3 id="s22title">Meenakshi Devidas</h3><p id="__p58" class="p p-first-last">No relationship to disclose</p></div><div id="s23" class="sec"><h3 id="s23title">Cheng Cheng</h3><p id="__p59" class="p p-first-last"><strong>Research Funding:</strong> Alpha Tau Pharmaceuticals (Inst)</p></div><div id="s24" class="sec"><h3 id="s24title">Deqing Pei</h3><p id="__p60" class="p p-first-last">No relationship to disclose</p></div><div id="s25" class="sec"><h3 id="s25title">Colton Smith</h3><p id="__p61" class="p p-first-last">No relationship to disclose</p></div><div id="s26" class="sec"><h3 id="s26title">William L. Carroll</h3><p id="__p62" class="p p-first-last">No relationship to disclose</p></div><div id="s27" class="sec"><h3 id="s27title">Elizabeth A. Raetz</h3><p id="__p63" class="p p-first-last">No relationship to disclose</p></div><div id="s28" class="sec"><h3 id="s28title">W. Paul Bowman</h3><p id="__p64" class="p p-first-last">No relationship to disclose</p></div><div id="s29" class="sec"><h3 id="s29title">Eric C. Larsen</h3><p id="__p65" class="p p-first-last">No relationship to disclose</p></div><div id="s30" class="sec"><h3 id="s30title">Kelly W. Maloney</h3><p id="__p66" class="p p-first-last">No relationship to disclose</p></div><div id="s31" class="sec"><h3 id="s31title">Paul L. Martin</h3><p id="__p67" class="p p-first"><strong>Consulting or Advisory Role:</strong> Jazz Pharmaceuticals</p><p id="__p68" class="p p-last"><strong>Research Funding:</strong> Novartis, Jazz Pharmaceuticals</p></div><div id="s32" class="sec"><h3 id="s32title">Leonard A. Mattano Jr</h3><p id="__p69" class="p p-first"><strong>Employment:</strong> Pfizer (I)</p><p id="__p70"><strong>Stock or Other Ownership:</strong> Pfizer (I), Amgen (I), Monsanto (I)</p><p id="__p71"><strong>Consulting or Advisory Role:</strong> Pfizer, Mylan, Novartis, Celldex Therapeutics</p><p id="__p72" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Pfizer, Mylan</p></div><div id="s33" class="sec"><h3 id="s33title">Naomi J. Winick</h3><p id="__p73" class="p p-first-last">No relationship to disclose</p></div><div id="s34" class="sec"><h3 id="s34title">Elaine R. Mardis</h3><p id="__p74" class="p p-first-last">No relationship to disclose</p></div><div id="s35" class="sec"><h3 id="s35title">Robert S. Fulton</h3><p id="__p75" class="p p-first-last">No relationship to disclose</p></div><div id="s36" class="sec"><h3 id="s36title">Deepa Bhojwani</h3><p id="__p76" class="p p-first-last"><strong>Consulting or Advisory Role:</strong> Amgen</p></div><div id="s37" class="sec"><h3 id="s37title">Scott C. Howard</h3><p id="__p77" class="p p-first"><strong>Honoraria:</strong> Sigma Tau Pharmaceuticals, Jazz Pharmaceuticals, Sanofi</p><p id="__p78"><strong>Consulting or Advisory Role:</strong> Sigma Tau Pharmaceuticals, Jazz Pharmaceuticals, Sanofi</p><p id="__p79" class="p p-last"><strong>Speakers’ Bureau:</strong> Sigma Tau Pharmaceuticals, Jazz Pharmaceuticals, Sanofi</p></div><div id="s38" class="sec"><h3 id="s38title">Sima Jeha</h3><p id="__p80" class="p p-first-last">No relationship to disclose</p></div><div id="s39" class="sec"><h3 id="s39title">Ching-Hon Pui</h3><p id="__p81" class="p p-first-last">No relationship to disclose</p></div><div id="s40" class="sec"><h3 id="s40title">Stephen P. Hunger</h3><p id="__p82" class="p p-first"><strong>Stock or Other Ownership:</strong> Express Scripts, Merck (I), Amgen (I), Pfizer (I)</p><p id="__p83"><strong>Honoraria:</strong> Jazz Pharmaceuticals, Sigma Tau Pharmaceuticals, Spectrum Pharmaceuticals</p><p id="__p84"><strong>Patents, Royalties, Other Intellectual Property:</strong> I am a co-inventor on a US patent #8568974 B2 Identification of novel subgroups of high-risk pediatric precursor-B acute lymphoblastic leukemia, outcome correlations and diagnostic and therapeutic methods related to same. It has not been licensed and there is no income</p><p id="__p85" class="p p-last"><strong>Travel, Accommodations, Expenses:</strong> Amgen</p></div><div id="s41" class="sec"><h3 id="s41title">William E. Evans</h3><p id="__p86" class="p p-first-last"><strong>Patents, Royalties, Other Intellectual Property:</strong> Patent for TPMT genotyping licensed by St Jude Children’s Research Hospital to Prometheus Laboratories</p></div><div id="s42" class="sec"><h3 id="s42title">Mignon L. Loh</h3><p id="__p87" class="p p-first-last">No relationship to disclose</p></div><div id="s43" class="sec sec-last"><h3 id="s43title">Mary V. Relling</h3><p id="__p88" class="p p-first-last">No relationship to disclose</p></div></div><div id="idm140355289628384" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140355289628384title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2007;<span class="ref-vol">49</span>:634–639.</span> [<a href="/pubmed/16937362" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Blood+Cancer&amp;title=Predicting+asparaginase-associated+pancreatitis&amp;author=HM+Knoderer&amp;author=J+Robarge&amp;author=DA+Flockhart&amp;volume=49&amp;publication_year=2007&amp;pages=634-639&amp;pmid=16937362&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Samarasinghe S, Dhir S, Slack J, et al.  Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. <span><span class="ref-journal">Br J Haematol. </span>2013;<span class="ref-vol">162</span>:710–713.</span> [<a href="/pubmed/23750892" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Incidence+and+outcome+of+pancreatitis+in+children+and+young+adults+with+acute+lymphoblastic+leukaemia+treated+on+a+contemporary+protocol,+UKALL+2003&amp;author=S+Samarasinghe&amp;author=S+Dhir&amp;author=J+Slack&amp;volume=162&amp;publication_year=2013&amp;pages=710-713&amp;pmid=23750892&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Silverman LB, Gelber RD, Dalton VK, et al.  Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">97</span>:1211–1218.</span> [<a href="/pubmed/11222362" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Improved+outcome+for+children+with+acute+lymphoblastic+leukemia:+Results+of+Dana-Farber+Consortium+Protocol+91-01&amp;author=LB+Silverman&amp;author=RD+Gelber&amp;author=VK+Dalton&amp;volume=97&amp;publication_year=2001&amp;pages=1211-1218&amp;pmid=11222362&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Raja RA, Schmiegelow K, Albertsen BK, et al.  Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol. <span><span class="ref-journal">Br J Haematol. </span>2014;<span class="ref-vol">165</span>:126–133.</span> [<a href="/pubmed/24428625" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Asparaginase-associated+pancreatitis+in+children+with+acute+lymphoblastic+leukaemia+in+the+NOPHO+ALL2008+protocol&amp;author=RA+Raja&amp;author=K+Schmiegelow&amp;author=BK+Albertsen&amp;volume=165&amp;publication_year=2014&amp;pages=126-133&amp;pmid=24428625&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Flores-Calderón J, Exiga-Gonzaléz E, Morán-Villota S, et al.  Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2009;<span class="ref-vol">31</span>:790–793.</span> [<a href="/pubmed/19770681" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr+Hematol+Oncol&amp;title=Acute+pancreatitis+in+children+with+acute+lymphoblastic+leukemia+treated+with+L-asparaginase&amp;author=J+Flores-Calderón&amp;author=E+Exiga-Gonzaléz&amp;author=S+Morán-Villota&amp;volume=31&amp;publication_year=2009&amp;pages=790-793&amp;pmid=19770681&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Vrooman LM, Stevenson KE, Supko JG, et al.  Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: Results from a randomized study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. <span><span class="ref-journal">J Clin Oncol. </span>2013;<span class="ref-vol">31</span>:1202–1210.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3595424/">PMC free article</a>]</span> [<a href="/pubmed/23358966" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Postinduction+dexamethasone+and+individualized+dosing+of+Escherichia+Coli+L-asparaginase+each+improve+outcome+of+children+and+adolescents+with+newly+diagnosed+acute+lymphoblastic+leukemia:+Results+from+a+randomized+study—Dana-Farber+Cancer+Institute+ALL+Consortium+Protocol+00-01&amp;author=LM+Vrooman&amp;author=KE+Stevenson&amp;author=JG+Supko&amp;volume=31&amp;publication_year=2013&amp;pages=1202-1210&amp;pmid=23358966&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Moghrabi A, Levy DE, Asselin B, et al.  Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:896–904.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1785142/">PMC free article</a>]</span> [<a href="/pubmed/17003366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Results+of+the+Dana-Farber+Cancer+Institute+ALL+Consortium+Protocol+95-01+for+children+with+acute+lymphoblastic+leukemia&amp;author=A+Moghrabi&amp;author=DE+Levy&amp;author=B+Asselin&amp;volume=109&amp;publication_year=2007&amp;pages=896-904&amp;pmid=17003366&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Avramis VI, Sencer S, Periclou AP, et al.  A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children’s Cancer Group study. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">99</span>:1986–1994.</span> [<a href="/pubmed/11877270" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=A+randomized+comparison+of+native+Escherichia+coli+asparaginase+and+polyethylene+glycol+conjugated+asparaginase+for+treatment+of+children+with+newly+diagnosed+standard-risk+acute+lymphoblastic+leukemia:+A+Children’s+Cancer+Group+study&amp;author=VI+Avramis&amp;author=S+Sencer&amp;author=AP+Periclou&amp;volume=99&amp;publication_year=2002&amp;pages=1986-1994&amp;pmid=11877270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Raja RA, Schmiegelow K, Frandsen TL. Asparaginase-associated pancreatitis in children. <span><span class="ref-journal">Br J Haematol. </span>2012;<span class="ref-vol">159</span>:18–27.</span> [<a href="/pubmed/22909259" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Haematol&amp;title=Asparaginase-associated+pancreatitis+in+children&amp;author=RA+Raja&amp;author=K+Schmiegelow&amp;author=TL+Frandsen&amp;volume=159&amp;publication_year=2012&amp;pages=18-27&amp;pmid=22909259&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Sadr-Azodi O, Mattsson F, Bexlius TS, et al.  Association of oral glucocorticoid use with an increased risk of acute pancreatitis: A population-based nested case-control study. <span><span class="ref-journal">JAMA Intern Med. </span>2013;<span class="ref-vol">173</span>:444–449.</span> [<a href="/pubmed/23440105" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA+Intern+Med&amp;title=Association+of+oral+glucocorticoid+use+with+an+increased+risk+of+acute+pancreatitis:+A+population-based+nested+case-control+study&amp;author=O+Sadr-Azodi&amp;author=F+Mattsson&amp;author=TS+Bexlius&amp;volume=173&amp;publication_year=2013&amp;pages=444-449&amp;pmid=23440105&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Halalsheh H, Bazzeh F, Alkayed K, et al.  6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2013;<span class="ref-vol">35</span>:470–472.</span> [<a href="/pubmed/23138114" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr+Hematol+Oncol&amp;title=6-Mercaptopurine-induced+recurrent+acute+pancreatitis+in+children+with+acute+lymphoblastic+leukemia/lymphoma&amp;author=H+Halalsheh&amp;author=F+Bazzeh&amp;author=K+Alkayed&amp;volume=35&amp;publication_year=2013&amp;pages=470-472&amp;pmid=23138114&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: An update. <span><span class="ref-journal">J Clin Gastroenterol. </span>2005;<span class="ref-vol">39</span>:709–716.</span> [<a href="/pubmed/16082282" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Gastroenterol&amp;title=Drug-induced+pancreatitis:+An+update&amp;author=CD+Trivedi&amp;author=CS+Pitchumoni&amp;volume=39&amp;publication_year=2005&amp;pages=709-716&amp;pmid=16082282&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Silverman LB, Stevenson KE, O’Brien JE, et al.  Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000) <span><span class="ref-journal">Leukemia. </span>2010;<span class="ref-vol">24</span>:320–334.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2820141/">PMC free article</a>]</span> [<a href="/pubmed/20016537" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Long-term+results+of+Dana-Farber+Cancer+Institute+ALL+Consortium+protocols+for+children+with+newly+diagnosed+acute+lymphoblastic+leukemia+(1985-2000)&amp;author=LB+Silverman&amp;author=KE+Stevenson&amp;author=JE+O’Brien&amp;volume=24&amp;publication_year=2010&amp;pages=320-334&amp;pmid=20016537&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Weetman RM, Baehner RL. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. <span><span class="ref-journal">Cancer. </span>1974;<span class="ref-vol">34</span>:780–785.</span> [<a href="/pubmed/4527863" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Latent+onset+of+clinical+pancreatitis+in+children+receiving+L-asparaginase+therapy&amp;author=RM+Weetman&amp;author=RL+Baehner&amp;volume=34&amp;publication_year=1974&amp;pages=780-785&amp;pmid=4527863&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Alvarez OA, Zimmerman G. Pegaspargase-induced pancreatitis. <span><span class="ref-journal">Med Pediatr Oncol. </span>2000;<span class="ref-vol">34</span>:200–205.</span> [<a href="/pubmed/10696127" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Pediatr+Oncol&amp;title=Pegaspargase-induced+pancreatitis&amp;author=OA+Alvarez&amp;author=G+Zimmerman&amp;volume=34&amp;publication_year=2000&amp;pages=200-205&amp;pmid=10696127&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Whitcomb DC, LaRusch J, Krasinskas AM, et al.  Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1349–1354.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3510344/">PMC free article</a>]</span> [<a href="/pubmed/23143602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Common+genetic+variants+in+the+CLDN2+and+PRSS1-PRSS2+loci+alter+risk+for+alcohol-related+and+sporadic+pancreatitis&amp;author=DC+Whitcomb&amp;author=J+LaRusch&amp;author=AM+Krasinskas&amp;volume=44&amp;publication_year=2012&amp;pages=1349-1354&amp;pmid=23143602&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Schneider A, Larusch J, Sun X, et al.  Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis. <span><span class="ref-journal">Gastroenterology. </span>2011;<span class="ref-vol">140</span>:162–171.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3171690/">PMC free article</a>]</span> [<a href="/pubmed/20977904" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Combined+bicarbonate+conductance-impairing+variants+in+CFTR+and+SPINK1+variants+are+associated+with+chronic+pancreatitis+in+patients+without+cystic+fibrosis&amp;author=A+Schneider&amp;author=J+Larusch&amp;author=X+Sun&amp;volume=140&amp;publication_year=2011&amp;pages=162-171&amp;pmid=20977904&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Witt H, Luck W, Hennies HC, et al.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">25</span>:213–216.</span> [<a href="/pubmed/10835640" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Mutations+in+the+gene+encoding+the+serine+protease+inhibitor,+Kazal+type+1+are+associated+with+chronic+pancreatitis&amp;author=H+Witt&amp;author=W+Luck&amp;author=HC+Hennies&amp;volume=25&amp;publication_year=2000&amp;pages=213-216&amp;pmid=10835640&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Szmola R, Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht’s enzyme Y. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2007;<span class="ref-vol">104</span>:11227–11232.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2040881/">PMC free article</a>]</span> [<a href="/pubmed/17592142" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Chymotrypsin+C+(caldecrin)+promotes+degradation+of+human+cationic+trypsin:+Identity+with+Rinderknecht’s+enzyme+Y&amp;author=R+Szmola&amp;author=M+Sahin-Tóth&amp;volume=104&amp;publication_year=2007&amp;pages=11227-11232&amp;pmid=17592142&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Sharer N, Schwarz M, Malone G, et al.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">339</span>:645–652.</span> [<a href="/pubmed/9725921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Mutations+of+the+cystic+fibrosis+gene+in+patients+with+chronic+pancreatitis&amp;author=N+Sharer&amp;author=M+Schwarz&amp;author=G+Malone&amp;volume=339&amp;publication_year=1998&amp;pages=645-652&amp;pmid=9725921&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Felderbauer P, Hoffmann P, Einwächter H, et al.  A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. <span><span class="ref-journal">BMC Gastroenterol. </span>2003;<span class="ref-vol">3</span>:34.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC317302/">PMC free article</a>]</span> [<a href="/pubmed/14641934" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Gastroenterol&amp;title=A+novel+mutation+of+the+calcium+sensing+receptor+gene+is+associated+with+chronic+pancreatitis+in+a+family+with+heterozygous+SPINK1+mutations&amp;author=P+Felderbauer&amp;author=P+Hoffmann&amp;author=H+Einwächter&amp;volume=3&amp;publication_year=2003&amp;pages=34&amp;pmid=14641934&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Heap GA, Weedon MN, Bewshea CM, et al.  HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. <span><span class="ref-journal">Nat Genet. </span>2014;<span class="ref-vol">46</span>:1131–1134.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6379053/">PMC free article</a>]</span> [<a href="/pubmed/25217962" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=HLA-DQA1-HLA-DRB1+variants+confer+susceptibility+to+pancreatitis+induced+by+thiopurine+immunosuppressants&amp;author=GA+Heap&amp;author=MN+Weedon&amp;author=CM+Bewshea&amp;volume=46&amp;publication_year=2014&amp;pages=1131-1134&amp;pmid=25217962&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Felderbauer P, Klein W, Bulut K, et al.  Mutations in the calcium-sensing receptor: A new genetic risk factor for chronic pancreatitis? <span><span class="ref-journal">Scand J Gastroenterol. </span>2006;<span class="ref-vol">41</span>:343–348.</span> [<a href="/pubmed/16497624" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Gastroenterol&amp;title=Mutations+in+the+calcium-sensing+receptor:+A+new+genetic+risk+factor+for+chronic+pancreatitis?&amp;author=P+Felderbauer&amp;author=W+Klein&amp;author=K+Bulut&amp;volume=41&amp;publication_year=2006&amp;pages=343-348&amp;pmid=16497624&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Mounzer R, Whitcomb DC. Genetics of acute and chronic pancreatitis. <span><span class="ref-journal">Curr Opin Gastroenterol. </span>2013;<span class="ref-vol">29</span>:544–551.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5654556/">PMC free article</a>]</span> [<a href="/pubmed/23872486" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Gastroenterol&amp;title=Genetics+of+acute+and+chronic+pancreatitis&amp;author=R+Mounzer&amp;author=DC+Whitcomb&amp;volume=29&amp;publication_year=2013&amp;pages=544-551&amp;pmid=23872486&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Pui CH, Sandlund JT, Pei D, et al.  Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">104</span>:2690–2696.</span> [<a href="/pubmed/15251979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Improved+outcome+for+children+with+acute+lymphoblastic+leukemia:+Results+of+Total+Therapy+Study+XIIIB+at+St+Jude+Children’s+Research+Hospital&amp;author=CH+Pui&amp;author=JT+Sandlund&amp;author=D+Pei&amp;volume=104&amp;publication_year=2004&amp;pages=2690-2696&amp;pmid=15251979&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Pui CH, Campana D, Pei D, et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:2730–2741.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2754320/">PMC free article</a>]</span> [<a href="/pubmed/19553647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Treating+childhood+acute+lymphoblastic+leukemia+without+cranial+irradiation&amp;author=CH+Pui&amp;author=D+Campana&amp;author=D+Pei&amp;volume=360&amp;publication_year=2009&amp;pages=2730-2741&amp;pmid=19553647&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Borowitz MJ, Devidas M, Hunger SP, et al.  Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children’s Oncology Group study. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>:5477–5485.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2424148/">PMC free article</a>]</span> [<a href="/pubmed/18388178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Clinical+significance+of+minimal+residual+disease+in+childhood+acute+lymphoblastic+leukemia+and+its+relationship+to+other+prognostic+factors:+A+Children’s+Oncology+Group+study&amp;author=MJ+Borowitz&amp;author=M+Devidas&amp;author=SP+Hunger&amp;volume=111&amp;publication_year=2008&amp;pages=5477-5485&amp;pmid=18388178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Borowitz MJ, Wood BL, Devidas M, et al.  Prognostic significance of minimal residual disease in high risk B-ALL: A report from Children’s Oncology Group study AALL0232. <span><span class="ref-journal">Blood. </span>2015;<span class="ref-vol">126</span>:964–971.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4543229/">PMC free article</a>]</span> [<a href="/pubmed/26124497" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Prognostic+significance+of+minimal+residual+disease+in+high+risk+B-ALL:+A+report+from+Children’s+Oncology+Group+study+AALL0232&amp;author=MJ+Borowitz&amp;author=BL+Wood&amp;author=M+Devidas&amp;volume=126&amp;publication_year=2015&amp;pages=964-971&amp;pmid=26124497&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation"> Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data (ed 2). New York, John Wiley &amp; Sons, 2002. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Kalbfleisch+JD,+Prentice+RL:+The+Statistical+Analysis+of+Failure+Time+Data+(ed+2).+New+York,+John+Wiley+&amp;+Sons,+2002.+" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Yang JJ, Cheng C, Devidas M, et al.  Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:237–241.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3104508/">PMC free article</a>]</span> [<a href="/pubmed/21297632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Ancestry+and+pharmacogenomics+of+relapse+in+acute+lymphoblastic+leukemia&amp;author=JJ+Yang&amp;author=C+Cheng&amp;author=M+Devidas&amp;volume=43&amp;publication_year=2011&amp;pages=237-241&amp;pmid=21297632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. <span><span class="ref-journal">Ann Stat. </span>1988;<span class="ref-vol">16</span>:1141–1154.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Stat&amp;title=A+class+of+K-sample+tests+for+comparing+the+cumulative+incidence+of+a+competing+risk&amp;author=RJ+Gray&amp;volume=16&amp;publication_year=1988&amp;pages=1141-1154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Ionita-Laza I, Lee S, Makarov V, et al.  Sequence kernel association tests for the combined effect of rare and common variants. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:841–853.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3675243/">PMC free article</a>]</span> [<a href="/pubmed/23684009" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Sequence+kernel+association+tests+for+the+combined+effect+of+rare+and+common+variants&amp;author=I+Ionita-Laza&amp;author=S+Lee&amp;author=V+Makarov&amp;volume=92&amp;publication_year=2013&amp;pages=841-853&amp;pmid=23684009&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Silverman LB, Stevenson K, Vrooman LM, et al.  Randomized comparison of IV peg and IM E. coli asparaginase in children and adolescents with acute lymphoblastic leukemia: Results of the DFCI ALL consortium protocol 05-01. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">118</span>:398–399.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Randomized+comparison+of+IV+peg+and+IM+E.+coli+asparaginase+in+children+and+adolescents+with+acute+lymphoblastic+leukemia:+Results+of+the+DFCI+ALL+consortium+protocol+05-01&amp;author=LB+Silverman&amp;author=K+Stevenson&amp;author=LM+Vrooman&amp;volume=118&amp;publication_year=2011&amp;pages=398-399&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation"> Dhall G, Robison NJ, Rubin JI, et al: Incidence of adverse reactions to post-induction asparaginase (ASP) therapy in children and adolescents with high-risk acute lymphoblastic leukemia (ALL): A report from the Children’s Oncology Group Study CCG-1961, J Clin Oncol 26, 2008 (suppl; abstr 10021) <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Dhall+G,+Robison+NJ,+Rubin+JI,+et+al:+Incidence+of+adverse+reactions+to+post-induction+asparaginase+(ASP)+therapy+in+children+and+adolescents+with+high-risk+acute+lymphoblastic+leukemia+(ALL):+A+report+from+the+Children’s+Oncology+Group+Study+CCG-1961,+J+Clin+Oncol+26,+2008+(suppl;+abstr+10021)+" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation"> Exome Aggregation Consortium (ExAC) data set.  <a href="http://exac.broadinstitute.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://exac.broadinstitute.org</a>.</span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation"> Tenner S, Baillie J, DeWitt J, et al: American College of Gastroenterology guideline: Management of acute pancreatitis. Am J Gastroenterol 108:1400-1415; 1416, 2013. [<a href="/pubmed/23896955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Catasús L, Vendrell J, Avilés FX, et al.  The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model. <span><span class="ref-journal">J Biol Chem. </span>1995;<span class="ref-vol">270</span>:6651–6657.</span> [<a href="/pubmed/7896805" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+sequence+and+conformation+of+human+pancreatic+procarboxypeptidase+A2.+cDNA+cloning,+sequence+analysis,+and+three-dimensional+model&amp;author=L+Catasús&amp;author=J+Vendrell&amp;author=FX+Avilés&amp;volume=270&amp;publication_year=1995&amp;pages=6651-6657&amp;pmid=7896805&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Witt H, Beer S, Rosendahl J, et al.  Variants in CPA1 are strongly associated with early onset chronic pancreatitis. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1216–1220.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3909499/">PMC free article</a>]</span> [<a href="/pubmed/23955596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Variants+in+CPA1+are+strongly+associated+with+early+onset+chronic+pancreatitis&amp;author=H+Witt&amp;author=S+Beer&amp;author=J+Rosendahl&amp;volume=45&amp;publication_year=2013&amp;pages=1216-1220&amp;pmid=23955596&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Belostotsky R, Seboun E, Idelson GH, et al.  Mutations in DHDPSL are responsible for primary hyperoxaluria type III. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:392–399.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2933339/">PMC free article</a>]</span> [<a href="/pubmed/20797690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Mutations+in+DHDPSL+are+responsible+for+primary+hyperoxaluria+type+III&amp;author=R+Belostotsky&amp;author=E+Seboun&amp;author=GH+Idelson&amp;volume=87&amp;publication_year=2010&amp;pages=392-399&amp;pmid=20797690&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Monico CG, Rossetti S, Belostotsky R, et al.  Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2011;<span class="ref-vol">6</span>:2289–2295.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3358997/">PMC free article</a>]</span> [<a href="/pubmed/21896830" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=Primary+hyperoxaluria+type+III+gene+HOGA1+(formerly+DHDPSL)+as+a+possible+risk+factor+for+idiopathic+calcium+oxalate+urolithiasis&amp;author=CG+Monico&amp;author=S+Rossetti&amp;author=R+Belostotsky&amp;volume=6&amp;publication_year=2011&amp;pages=2289-2295&amp;pmid=21896830&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Jiang J, Johnson LC, Knight J, et al.  Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. <span><span class="ref-journal">Am J Physiol Gastrointest Liver Physiol. </span>2012;<span class="ref-vol">302</span>:G637–G643.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3311310/">PMC free article</a>]</span> [<a href="/pubmed/22207577" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Gastrointest+Liver+Physiol&amp;title=Metabolism+of+[13C5]hydroxyproline+in+vitro+and+in+vivo:+implications+for+primary+hyperoxaluria&amp;author=J+Jiang&amp;author=LC+Johnson&amp;author=J+Knight&amp;volume=302&amp;publication_year=2012&amp;pages=G637-G643&amp;pmid=22207577&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">Niederau C, Niederau M, Lüthen R, et al.  Pancreatic exocrine secretion in acute experimental pancreatitis. <span><span class="ref-journal">Gastroenterology. </span>1990;<span class="ref-vol">99</span>:1120–1127.</span> [<a href="/pubmed/2394333" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Pancreatic+exocrine+secretion+in+acute+experimental+pancreatitis&amp;author=C+Niederau&amp;author=M+Niederau&amp;author=R+Lüthen&amp;volume=99&amp;publication_year=1990&amp;pages=1120-1127&amp;pmid=2394333&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Frick TW. The role of calcium in acute pancreatitis. <span><span class="ref-journal">Surgery. </span>2012;<span class="ref-vol">152</span>(suppl 1):S157–S163.</span> [<a href="/pubmed/22906890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Surgery&amp;title=The+role+of+calcium+in+acute+pancreatitis&amp;author=TW+Frick&amp;volume=152&amp;issue=suppl+1&amp;publication_year=2012&amp;pages=S157-S163&amp;pmid=22906890&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Ueda T, Takeyama Y, Kaneda K, et al.  Protective effect of a microtubule stabilizer taxol on caerulein-induced acute pancreatitis in rat. <span><span class="ref-journal">J Clin Invest. </span>1992;<span class="ref-vol">89</span>:234–243.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC442841/">PMC free article</a>]</span> [<a href="/pubmed/1370296" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Protective+effect+of+a+microtubule+stabilizer+taxol+on+caerulein-induced+acute+pancreatitis+in+rat&amp;author=T+Ueda&amp;author=Y+Takeyama&amp;author=K+Kaneda&amp;volume=89&amp;publication_year=1992&amp;pages=234-243&amp;pmid=1370296&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Vora A, Goulden N, Mitchell C, et al.  Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial. <span><span class="ref-journal">Lancet Oncol. </span>2014;<span class="ref-vol">15</span>:809–818.</span> [<a href="/pubmed/24924991" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Augmented+post-remission+therapy+for+a+minimal+residual+disease-defined+high-risk+subgroup+of+children+and+young+people+with+clinical+standard-risk+and+intermediate-risk+acute+lymphoblastic+leukaemia+(UKALL+2003):+A+randomised+controlled+trial&amp;author=A+Vora&amp;author=N+Goulden&amp;author=C+Mitchell&amp;volume=15&amp;publication_year=2014&amp;pages=809-818&amp;pmid=24924991&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4962704&amp;issue-id=273258&amp;journal-id=660&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140355217823152title">Abstract</a></li><li><a href="#s1title">INTRODUCTION</a></li><li><a href="#s2title">METHODS</a></li><li><a href="#s9title">RESULTS</a></li><li><a href="#s15title">DISCUSSION</a></li><li><a href="#__sec5title">Supplementary Material</a></li><li><a href="#idm140355219654624title">Footnotes</a></li><li><a href="#s17title">AUTHOR CONTRIBUTIONS</a></li><li><a href="#s18title">AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</a></li><li><a href="#idm140355289628384title">REFERENCES</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Journal of Clinical Oncology</span> are provided here courtesy of <strong>American Society of Clinical Oncology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4962704/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4962704/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4962704/pdf/JCO645812.pdf">PDF (911K)</a></li> | <li><a href="#" data-citationid="PMC4962704" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962704%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962704%2F&amp;text=Clinical%20and%20Genetic%20Risk%20Factors%20for%20Acute%20Pancreatitis%20in%20Patients%20With%20Acute%20Lymphoblastic%20Leukemia" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962704%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="27114598" data-aiid="4962704" data-aid="4962704" data-iid="273258" data-domainid="660" data-domain="jco" data-accid="PMC4962704" data-md5="7afbbcb7dd4b85e8d30ce6b591a1c405"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T14:39:44-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal103&amp;ncbi_phid=CE8A1BF6DD592E01000000000250015E&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4962704%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jco&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4962704/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>